Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 2
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Profile of brentuximab vedotin and its potential in the treatment of relapsed or refractory Hodgkin lymphoma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,972 | Dovepress* | 10,972+ | 2,518 | 13,490 | |
Totals | 10,972 | 2,518 | 13,490 | ||
*Since 21 May 2012 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 2 | 2 |
View citations on Google Scholar